Dr. Reddy’s Laboratories shares in focus after acquiring India trademarks for two HRT drugs for $32 million
The $32 million acquisition enhances Dr. Reddy’s market position in India by expanding its gynecology portfolio and entering the hormone replacement t...
Read Full Article →